Skip to main content
Abnova logo

Abnova — Investor Relations & Filings

Ticker · 4133 ISIN · TW0004133004 TW Professional, scientific and technical activities
Filings indexed 1,503 across all filing types
Latest filing 2016-11-14 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
105年第3季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by the company 亞諾法. It includes specific financial figures, investment methods, and regulatory limits, indicating substantive financial data rather than a mere announcement. The document length is 1296 characters, which is relatively short, but the content is detailed and specific to investment reporting. This type of disclosure aligns with regulatory filings related to investment activities and financial reporting but does not fit the definitions of Annual Report, Interim Report, or other detailed financial statements. It is a regulatory disclosure of investment information, which fits best under Regulatory Filings (RNS) as a general category for such compliance disclosures that do not fit other specific categories.
2016-11-14 Chinese
105年第3季財務報告書 — 201604_4133_AI3.zip
Regulatory Filings
2016-11-14 Chinese
105年第3季財務報告書 — 201604_4133_AI1.zip
Regulatory Filings
2016-11-14 Chinese
105年第3季財務報告書 — 201603_4133_AI1.pdf
Regulatory Filings
2016-11-14 Chinese
105年第3季財務報告書 — 201602_4133_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled "合併財務報告暨會計師核閱報告" which translates to "Consolidated Financial Report and Auditor's Review Report". It covers the periods 民國 105 年及 104 年第二季, which correspond to the second quarter of years 2016 and 2015. The content includes consolidated balance sheets, income statements, cash flow statements, notes to financial statements, and an auditor's review report. The presence of detailed financial statements and auditor's review indicates this is a comprehensive interim or quarterly financial report rather than just an announcement or a standalone audit report. The document length is 15,000 characters, which is substantial and consistent with a full interim report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2016
2016-11-14 Chinese
105年第3季財務報告書 — 201601_4133_AI1.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "合併財務報告暨會計師核閱報告" which translates to "Consolidated Financial Report and Accountant's Review Report" for the first quarter of the years 105 and 104 (Taiwanese calendar years corresponding to 2016 and 2015). It includes detailed financial statements such as consolidated balance sheets, income statements, statements of changes in equity, cash flow statements, and notes to the financial statements. The presence of an accountant's review report (核閱報告) indicates this is a reviewed interim financial report rather than a full annual report. The period covered is a quarter (first quarter), and the document length is substantial (15,000 characters), containing actual financial data and analysis. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2016
2016-11-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.